Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05338697 · ClinicalTrials.gov registry record
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
A clinical trial of Stroke and Stroke, Ischemic, sponsored by University of Cincinnati.
- Recruiting
- Registry status
- 657
- Enrollment target
- 20
- Study locations
NCT05338697: Recruiting study of Stroke and Stroke, Ischemic, sponsored by University of Cincinnati.
NCT05338697 is a study of Stroke and Stroke, Ischemic that is actively recruiting participants, run by University of Cincinnati. The registered enrollment target is 657 participants, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (95% lower). The trial reports 20 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05338697, a study of Stroke and Stroke, Ischemic, is actively recruiting participants, sponsored by University of Cincinnati.
- RECRUITING
- Registry status
- 657 participants
- Enrollment target
- 20
- Study locations
Study Summary
VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, and explore these biomarkers in acute intracerebral hemorrhage. VERIFY will create the first multicenter, large-scale, prospective dataset of clinical, transmagnetic stimulation (TMS), and MRI measures in the acute stroke time window.
Primary Outcome
UE-FM score, as a continuous scale, adjusted for baseline score in analysis
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Transcranial Magnetic Stimulation (TMS)
Study Locations (20)
California
- Keck Medical Center of USC - Los Angeles
- Ronald Reagan UCLA Medical Center - Los Angeles
- Kaiser Permanente Redwood City Medical Center - Redwood City
- San Francisco General Hospital - San Francisco
- UCSF Medical Center - San Francisco
Massachusetts
- Massachusetts General Hospital - Boston
- Lahey Hospital & Medical Center - Burlington
- Baystate Medical Center - Springfield
Alabama
- Birmingham VA Medical Center - Birmingham
- University of Alabama - Birmingham
Illinois
- Memorial Hospital of Carbondale - Carbondale
- Advocate Lutheran General Hospital - Park Ridge
Arizona
- Banner University Medical Center - Tucson
Connecticut
- Yale New Haven Hospital - New Haven
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Georgia
- Emory University Hospital - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 657 participants |
| Start Date | 2022-06-18 |
| Est. Completion | 2027-10 |
What NCT05338697 shows while recruiting
NCT05338697 is an observational study that tracks outcomes without assigning an intervention. The registered 657 participants enrollment target is mid-sized for trials with a published cap, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (95% lower).
The record links to 3 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Transcranial Magnetic Stimulation (TMS) is the first listed.
NCT05338697 names 20 study sites across 12 states, led by California, Massachusetts, Alabama.
Frequently Asked Questions
What is clinical trial NCT05338697 about?
NCT05338697 is a clinical study titled "Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials". VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, and explore these biomarkers in acute intracerebral hemorrhage. VERIFY will create the first multicenter, large-scale, prospective dataset of clinical, tran...
What is the current status of trial NCT05338697?
This trial is currently recruiting. The enrollment target is 657 participants. The study started on 2022-06-18. Estimated completion is 2027-10.
What conditions does trial NCT05338697 study?
This clinical trial studies the following conditions: Stroke, Stroke, Ischemic, Stroke, Acute.
What interventions are being tested in trial NCT05338697?
The interventions under investigation include: Transcranial Magnetic Stimulation (TMS) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05338697?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05338697 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Connecticut, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05338697's enrollment target sits among peer trials
657 46th of 454 higher than 409 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The SLEEPR Study: SLEep Effects on Post-stroke Rehabilitation
RECRUITING
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
RECRUITING
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03671044 · 657 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients
- NCT05407129 · 656 participants · NA
Patients and Families Improving Safety in Hospitals by Actively Reporting Experiences
- NCT06127199 · 656 participants · NA
Contraceptive Efficacy Study of Ovaprene
- NCT07216742 · 659 participants · Phase 3
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI